Other languages AtriCure, Inc.

Equities

ATRC

US04963C2098

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-26 EDT			5-day change	1st Jan Change
23 ^USD	+8.08%		-3.22%	-35.56%

05-14	Transcript : AtriCure, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:15 AM
05-02	Needham Lowers AtriCure's PT to $40 From $46 Due to Peer Multiple Contraction, Keeps Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AtriCure, Inc. Provides Earnings Guidance for the Year 2024	05-01
AtriCure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-01
AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management	04-18
AtriCure Insider Sold Shares Worth $307,510, According to a Recent SEC Filing	03-07
Atricure, Inc. Appoints Shlomi Nachman as Director, Member of Each of the Board?s Strategy Committee and Compliance, Quality and Risk Committee	02-27
AtriCure Q4 Loss Widens, Revenue Rises; 2024 Guidance Set	02-15
Atricure, Inc. Provides Earnings Guidance for 2024	02-15
AtriCure, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-15
AtriCure Reports Higher Preliminary Q4, 2023 Revenue; Issues 2024 Revenue Guidance; Shares Rise	01-08
Atricure, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023 and Provides Financial Guidance for the Year 2024	01-08
AtriCure, Inc. Appoints Shlomi Nachman to its Board of Directors	01-04
AtriCure's Q3 Adjusted Loss Narrows, Revenue Rises; Full-Year Guidance Adjusted	11-01
AtriCure, Inc. Provides Revenue Guidance for the 2023	11-01
AtriCure, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-01
Insider Sell: Atricure	23-07-28
AtriCure Q2 Non-GAAP Loss Narrows as Sales Increase	23-07-25
Atricure, Inc. Provides Revenue Guidance for the Year 2023	23-07-25
AtriCure, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-25
Insider Sell: Atricure	23-05-30
Insider Sell: Atricure	23-05-03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages AtriCure, Inc.

Equities

ATRC

US04963C2098

Other languages

Filters